English
繁體中文
简体中文
日本語
AxonTracking Assay Competition
August 4, 2022
Track your Axon to WIN! The Deadline for entries has been extended to Wednesday 12th October. Do you have a cool image of a tracked neuron using our AxonTracking Assay? Share your image and you could win a $2000 Travel Grant to SfN 2022 in San Diego this November! How to Participate: Send an email to info@mxwbio.com with the subject: AxonTracking Assay Competition Attach the image or link and share a short description of the experiment (max. 100 words) Good…
MaxWell Biosystems Around the World
August 3, 2022
Travel Blog | Summer 2022 We caught up with some of our MaxWellers that have been busy representing MaxWell Biosystems around the world at lots of conferences such as ISSCR, FENS, CAN and lots more in between. After some rest we wanted to know all about their life while traveling and any hints and tips they might have to share. Here is what they had to say! That’s all for now! Let us know if you enjoyed…
HyVIS project
December 8, 2021
MaxWell Biosystems Becomes a Key Partner in a €3M EU-Financed Project “HyVIS”: Next Generation Prosthesis for Visual Restoration Hybrid Synapse for Vision (HyVIS) is a project funded by European Union Horizon 2020 FET-OPEN program 1, which aims to combine several technologies to achieve the groundbreaking restoration of synaptic light-mediated input in retinas with impaired photoreceptors, leading to treatments for diseases such as in retinitis pigmentosa and age-related macular degeneration (AMD). The key focus of HyVIS project is the development of an artificial light-sensitive prosthesis,…
Look back: the first In-vitro 2D and 3D Neuronal Networks Summit (MaxWell Biosystems User Meeting)
June 23, 2021
On April 22nd and 23rd, we hosted the first In-vitro 2D and 3D neuronal Networks Summit (MaxWell Biosystems User Meeting) and were very excited about the tremendously successful outcome, with over 700 registrants from 49 countries! First Day: Scientific Talks and Discussions Open for All The first day of the meeting was open to everybody. We had very interesting talks from seven invited speakers, who spoke about their work involving iPSC-derived neurons, brain organoids, and also high-density microelectrode array (HD-MEA)…
HD-MEAs play a role in the functional characterization of human iPSC-derived dopaminergic neurons
June 22, 2021
Maria Sundberg from the Boston Children’s Hospital, Harvard Medical School, and colleagues, recently reported in Nature Communications a study on the reciprocal copy number variations (CNVs) of 16p11.2 gene region, associated with a wide spectrum of neuropsychiatric and neurodevelopmental disorders. For the functional analysis of the developing iPSC-derived dopaminergic (DA) neuron network, complementary-metal-oxide-semiconductor (CMOS)-based high-density microelectrode arrays (HD-MEAs), MaxOne System by MaxWell Biosystems was extensively used. 16p.11.2 Reciprocal copy number variations (CNVs) in neuropsychiatric disorders 16p.11.2 CNVs have been implicated in…
Observing the activity of human-derived neurons in health and in disease
April 9, 2021
The combination of two technologies—induced pluripotent stem cells and high-density microelectrode arrays—offers an unprecedented platform to study human brain activity in detail outside the body. Back in 2006, Prof. Yamanaka and colleagues revealed a technique to reprogram adult skin cells into embryonic-like cells called induced pluripotent stem cells or iPSCs. This Nobel Prize winning technology enables access to human neurons derived from adult blood or skin cells in a high-throughput manner, thus opening up the possibilities to study neurological…
MaxWell Biosystems Completes CHF 4 million Series A Financing Round
December 16, 2020
Zurich, Switzerland, 16 December 2020 – MaxWell Biosystems AG, a spin-off from ETH Zürich founded in 2016 announced today the closing of a CHF 4 million Series A financing round to further industrialize and scale-up the production of their consumables, so called multiwell high-density microelectrode array (HD-MEA) plates. Such scale-up will enable the customers of MaxWell Biosystems in the pharmaceutical industry to run functional drug screenings at a higher throughput and ultimately contribute to accelerate the development of drugs targeting…
MaxWell Biosystems introduces its new headquarters in Zurich
November 12, 2020
Since 2016, MaxWell Biosystems was located in the same premises as the Department of Biosystems Science and Engineering at ETH Zurich in Basel. With the growing team and the need for our own headquarters, we searched and found our new home in Zurich. With the dynamic startup ecosystem, world-class universities, and of course the beautiful lake and mountains, Zurich is a great place for MxW. It is here where we will continue to grow the team, develop new products, and connect to…
Neuroservice and MaxWell Biosystems announce strategic partnership
October 28, 2020
Neuroservice and MaxWell Biosystems announce strategic partnership to develop HD-MEA assays for human iPSC-derived neurons and other cell cultures Aix-en-Provence, FRANCE and Zurich, SWITZERLAND – October 28, 2020. Today, Neuroservice and MaxWell Biosystems are thrilled to announce a strategic partnership aiming to provide the pharmaceutical industry with a new state-of-the-art CNS in vitro cell electrophysiological solution based on high-density microelectrode array recording of human iPSC-derived neurons and other neuron cultures. The partnership will combine the MaxTwo high-density microelectrode array (HD-MEA)…
MaxWell Biosystems appoints Dr. Marcel Suter as new VP Operations
September 30, 2020
Zurich, Switzerland – September 30, 2020 MaxWell Biosystems AG is pleased to announce the appointment of Dr. Marcel Suter as the new Vice President of Operations, effective September 1, 2020. In this new position, Dr. Suter will oversee the company’s operational units, including, supply chain, production, logistics, procurement, and quality control. He will report directly to Dr. Urs Frey, CEO. With more than eight years of experience as project manager and as VP Operations at Optotune, an optics company, Dr.…
Capture the activity of thousands of communicating neurons all at once
September 25, 2020
Latest Neurochip published in Nature Communications Today, a new generation of high-density microelectrode array (HD-MEA) technology has been published in Nature Communications (link). This publication not only demonstrates the excellent performance of the chip, but also describes the large-scale extraction of neuronal metrics, such as axonal conduction velocity, and includes impressive showcases of applications with various neuronal preparations. The developed versatile platform for label-free, live-cell electrical imaging will further accelerate drug discovery and basic research in the field of neuroscience.…
Cell Story Challenge Winners
March 7, 2019
We are excited to announce the winners of our first Cell Story Challenge. Lill Eva Johansen BCRM, UMC Utrecht, Utrecht University, The Netherlands Neural Circuit Development and Disease Lab – Dr. Jeroen Pasterkamp Research Goal: Interrogating human iPSC-derived motor neurons about nerve conduction in an in vitro model of multifocal motor neuropathy Background and motivation:Multifocal Motor Neuropathy (MMN) is a motor neuron-specific autoimmune neuropathy with the electrophysiological hallmark of conduction block, causing asymmetrical weakness in distal parts of limbs which…
10 Years Venture Kick Ceremony | MaxWell Biosystems is a Global Shaper
November 30, 2017
MaxWell Biosystems joined the celebration of Venture Kick’s 10-year anniversary last 29 November 2017. Held in Schlieren, the ceremony welcomed 500 guests–all involved in the Swiss innovation, entrepreneurship, and investment community. Venture Kick included a variety of events during the evening, such as a startup exhibition, speeches, guitar concert, and a fashion show. Everyone enjoyed the sumptuous dinner, desserts, and drinks. Global Shapers Venture Kick nominated high-impact startups for each of the ten years since the program started. The Global…
MaxWell Biosystems at European Retina Meeting 2017
October 10, 2017
From October 5th to the 7th, MaxWell Biosystems hosted a booth at the European Retina Meeting, in Paris, France. The conference attracted retina experts, researchers, and students. Paris was a great host, and MaxWell Biosystems even had the opportunity to attend a gala dinner in the city. MaxWell Biosystems would like to thank the organizers for a job well done! Conference attendees loved the levitating MaxOne chip on display. Additionally, ERM 2017 gave MaxWell Biosystems the opportunity to debut the brand new Tissue Holder, specifically made for retinal applications. We’re excited to…
MaxWell Biosystems at iForum 2017 in London
October 1, 2017
On September 28, 2017, MaxWell Biosystems’ VP of Scientific Affairs, Michele Fiscella, travelled to London to meet with stem cell researchers from academia, and the pharma and biotech industries. Michele presented results from using the MaxOne platform with induced pluripotent stem cells (iPSCs) in a presentation titled, “High-resolution microelectrode array platform for biomarker discovery and novel functional assays with human iPSC-derived neurons.” After presenting promising results and receiving a positive reception from researchers at iForum, Michele is excited about the potential for using MaxWell Biosystems’…
MaxWell Biosystems technology in “The Secrets of Vision”
September 8, 2017
MaxWell Biosystems was excited to see Dr. Michele Fiscella, VP Scientific Affairs, featured in “The Secrets of Vision”. Michele discussed the state of vision disease research. The video is part of a film series produced by Systems X, the Swiss Initiative in Systems Biology. “The Secrets of Vision” tracks the increasing importance of research on vision-related diseases — with the end goal of developing effective drugs and treatment. In the feature, Michele explains how high-density microelectrode array systems, such as MaxOne, can accelerate this type of retinal cell research. He comments, “High…
MaxWell Biosystems recognized in Top 100 Swiss Startups 2017
September 7, 2017
“Top 100 Swiss Startup Award,” September 6, 2017 MaxWell Biosystems is honored to be recognized as one of the Top 100 Swiss startups of 2017! The list is published each year by IFJ and startup.ch and all of the best Swiss startups are included. CEO Urs Frey and CTO Jan Muller attended the awards ceremony in Zurich. See MaxWell Biosystems and all of the Top 100 startups in Startup Ticker’s Official News Release >>
MaxWell Biosystems Featured at ETH Industry Day 2017
September 1, 2017
ETH Industry Day, August 29, 2017 With 600 attendees, ranging from ETH researchers to industry experts, ETH Industry Day 2017 brought together the research and industry community to inspire attendees about the current stage of research and technology at ETH. As a spin-off that is successfully bringing technology from academia into industry, MaxWell Biosystems was proud to present. The event was a great opportunity to network with leaders, researchers, and industry members from the ETH community. It was exciting to start discussions across many…
MaxWell Biosystems at the 2017 ISN-ESN Meeting in Paris
August 29, 2017
From August 20 to 24th, MaxWell Biosystems exhibited a booth at the 2017 Biennial Meeting of the International Society of Neurochemistry in Paris, France. CEO, Dr. Urs Frey, and Dr. Michele Fiscella were excited to discuss how the MaxOne high-resolution electrophysiology platform can be used for applications in neurochemistry with conference attendees. MaxWell Biosystems looks forward to connecting with neurochemistry researchers interested in using MaxOne and MaxTwo for their research.
MaxWell Biosystems at the Annual Meeting of the Japanese Neuroscience Society (JNS) 2017
August 18, 2017
MaxWell Biosystems travelled to Chiba, Japan and exhibited at the 40th Annual Meeting of the Japanese Neuroscience Society from July 20th to 23rd. CEO, Dr. Urs Frey, and Dr. Marie Obien were excited to show off both the MaxOne and MaxTwo systems at this year’s Japanese neuroscience conference focused on “Pushing the Boundaries of Neuroscience.” MaxWell Biosystems received a warm reception from the Japanese neuroscience community, and we look forward to connecting with researchers excited about using the MaxOne and MaxTwo. We will return to the conference next year in…